Natalizumab in progressive MS: Results of an open-label, phase 2A, proof-of-concept trial

Jeppe Romme Christensen, Rikke Ratzer, Lars Börnsen, Mark Lyksborg, Ellen Garde, Tim B Dyrby, Hartwig R Siebner, Per S Sorensen, Finn Sellebjerg

80 Citationer (Scopus)

Fingeraftryk

Dyk ned i forskningsemnerne om 'Natalizumab in progressive MS: Results of an open-label, phase 2A, proof-of-concept trial'. Sammen danner de et unikt fingeraftryk.

Medicin og biovidenskab